Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 3 |
NetGPI | no | yes: 0, no: 3 |
Related structures:
AlphaFold database: A4IBG9
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 119 | 121 | PF00675 | 0.582 |
CLV_PCSK_KEX2_1 | 119 | 121 | PF00082 | 0.582 |
DEG_APCC_DBOX_1 | 44 | 52 | PF00400 | 0.494 |
DEG_APCC_DBOX_1 | 78 | 86 | PF00400 | 0.485 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.533 |
DOC_CYCLIN_yCln2_LP_2 | 34 | 37 | PF00134 | 0.575 |
DOC_MAPK_MEF2A_6 | 52 | 61 | PF00069 | 0.406 |
DOC_PP1_RVXF_1 | 74 | 81 | PF00149 | 0.690 |
DOC_PP2B_LxvP_1 | 34 | 37 | PF13499 | 0.575 |
DOC_PP4_FxxP_1 | 80 | 83 | PF00568 | 0.575 |
LIG_Actin_WH2_2 | 63 | 81 | PF00022 | 0.499 |
LIG_FHA_2 | 104 | 110 | PF00498 | 0.556 |
LIG_GBD_Chelix_1 | 70 | 78 | PF00786 | 0.421 |
LIG_SH2_NCK_1 | 101 | 105 | PF00017 | 0.593 |
LIG_SH2_STAT5 | 11 | 14 | PF00017 | 0.538 |
LIG_SUMO_SIM_anti_2 | 53 | 60 | PF11976 | 0.404 |
MOD_CK1_1 | 102 | 108 | PF00069 | 0.557 |
MOD_CK2_1 | 103 | 109 | PF00069 | 0.558 |
MOD_GlcNHglycan | 93 | 96 | PF01048 | 0.554 |
MOD_GSK3_1 | 99 | 106 | PF00069 | 0.562 |
TRG_DiLeu_BaEn_1 | 53 | 58 | PF01217 | 0.403 |
TRG_ENDOCYTIC_2 | 101 | 104 | PF00928 | 0.597 |
TRG_NES_CRM1_1 | 46 | 60 | PF08389 | 0.443 |
TRG_Pf-PMV_PEXEL_1 | 89 | 93 | PF00026 | 0.572 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A3Q8IVA6 | Leishmania donovani | 99% | 100% |
E9AF83 | Leishmania major | 80% | 76% |